➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Dow
Mallinckrodt
Harvard Business School
AstraZeneca

Last Updated: May 16, 2021

DrugPatentWatch Database Preview

CLOBETASOL PROPIONATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Clobetasol Propionate patents expire, and when can generic versions of Clobetasol Propionate launch?

Clobetasol Propionate is a drug marketed by Glenmark Pharms Ltd, Ingenus Pharms Llc, Perrigo Israel, Perrigo Uk Finco, Taro, Aleor Dermaceuticals, Amneal, Cosette, Encube, Fougera Pharms Inc, Glasshouse Pharms, Glenmark Pharms, Lupin Ltd, Mylan, Rising, Teligent, Teva Pharms Usa, Torrent, Xiromed, Zydus Pharms, Fougera Pharms, Perrigo Co, Actavis Mid Atlantic, Akorn, Cadila, Novel Labs Inc, Taro Pharms, Macleods Pharms Ltd, Prinston Inc, Saptalis Pharms, Tolmar, Wockhardt Bio Ag, Apotex, Paddock Llc, and Ani Pharms Inc. and is included in seventy-five NDAs.

The generic ingredient in CLOBETASOL PROPIONATE is clobetasol propionate. There are fourteen drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Clobetasol Propionate

A generic version of CLOBETASOL PROPIONATE was approved as clobetasol propionate by COSETTE on February 16th, 1994.

  Get Started for $10

Drug patent expirations by year for CLOBETASOL PROPIONATE
Drug Prices for CLOBETASOL PROPIONATE

See drug prices for CLOBETASOL PROPIONATE

Drug Sales Revenue Trends for CLOBETASOL PROPIONATE

See drug sales revenues for CLOBETASOL PROPIONATE

Recent Clinical Trials for CLOBETASOL PROPIONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cairo UniversityPhase 3
Skane University HospitalPhase 2/Phase 3
Malmö UniversityPhase 2/Phase 3

See all CLOBETASOL PROPIONATE clinical trials

Pharmacology for CLOBETASOL PROPIONATE
Medical Subject Heading (MeSH) Categories for CLOBETASOL PROPIONATE
Paragraph IV (Patent) Challenges for CLOBETASOL PROPIONATE
Tradename Dosage Ingredient NDA Submissiondate
IMPOYZ CREAM;TOPICAL clobetasol propionate 209483 2019-12-06
OLUX E AEROSOL, FOAM;TOPICAL clobetasol propionate 022013 2010-02-25
CLOBEX SPRAY;TOPICAL clobetasol propionate 021835 2008-09-29
CLOBEX SHAMPOO;TOPICAL clobetasol propionate 021644 2008-01-09
CLOBEX LOTION;TOPICAL clobetasol propionate 021535 2006-03-27
OLUX AEROSOL, FOAM;TOPICAL clobetasol propionate 021142 2005-06-27

US Patents and Regulatory Information for CLOBETASOL PROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc CLOBETASOL PROPIONATE (EMOLLIENT) clobetasol propionate CREAM;TOPICAL 075733-001 Aug 22, 2001 AB2 RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Novel Labs Inc CLOBETASOL PROPIONATE clobetasol propionate OINTMENT;TOPICAL 208841-001 May 4, 2018 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Teligent CLOBETASOL PROPIONATE clobetasol propionate LOTION;TOPICAL 208667-001 Nov 29, 2016 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Aleor Dermaceuticals CLOBETASOL PROPIONATE clobetasol propionate SHAMPOO;TOPICAL 213290-001 May 18, 2020 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Taro CLOBETASOL PROPIONATE clobetasol propionate SOLUTION;TOPICAL 075224-001 Nov 16, 1998 AT RX No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Harvard Business School
Boehringer Ingelheim
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.